Tom Foltynie Selected Research

Tom Foltynie Research Topics

Disease

39	Parkinson Disease (Parkinson's Disease) 01/2022 - 04/2004
4	Tourette Syndrome (Tourette's Syndrome) 04/2021 - 02/2011
3	Movement Disorders (Movement Disorder) 01/2022 - 01/2015
3	Tremor (Tremors) 01/2022 - 07/2017
3	Disease Progression 01/2020 - 12/2013
3	Cognitive Dysfunction 01/2017 - 09/2013
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 01/2019
2	Hypokinesia (Bradykinesia) 01/2018 - 08/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 04/2004
2	Gaucher Disease (Gaucher's Disease) 05/2014 - 02/2013
2	Dyskinesias (Dyskinesia) 01/2014 - 03/2012
1	Dementia (Dementias) 12/2021
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 11/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2019
1	Synucleinopathies 05/2018
1	Mood Disorders (Mood Disorder) 01/2018
1	Mental Disorders (Mental Disorder) 03/2016
1	Chorea (Rheumatic Chorea) 03/2012
1	Huntington Disease (Huntington's Disease) 03/2012
1	Dystonia (Limb Dystonia) 03/2012
1	Neuroacanthocytosis 03/2012
1	Dysarthria (Spastic Dysarthria) 11/2011
1	Neoplasms (Cancer) 06/2006
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 06/2006

Drug/Important Bio-Agent (IBA)

7	Glucosylceramidase (Glucocerebrosidase)IBA 01/2022 - 01/2013
7	Levodopa (L Dopa)FDA LinkGeneric 01/2019 - 03/2012
2	Capsules (Microcapsules)IBA 01/2022 - 01/2019
2	Dopamine (Intropin)FDA LinkGeneric 11/2020 - 01/2016
2	opicaponeIBA 11/2020 - 10/2018
2	Ambroxol (Mucosolvan)IBA 01/2020 - 05/2014
2	Dihydroxyphenylalanine (Dopa)IBA 01/2020 - 01/2018
2	Monoamine Oxidase (MAO)IBA 10/2018 - 01/2014
2	AcidsIBA 01/2017 - 02/2013
1	Cholinergic Agents (Cholinergics)IBA 12/2021
1	ropinirole (Requip)FDA LinkGeneric 11/2020
1	Dopamine Agonists (Dopamine Agonist)IBA 11/2020
1	entacapone (Comtan)FDA Link 11/2020
1	ThiazolidinedionesIBA 10/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2020
1	insulin receptor-related receptor (IRR)IBA 10/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2020
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 10/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2020
1	Exenatide (Byetta)FDA Link 01/2020
1	catechol (pyrocatechol)IBA 10/2018
1	safinamideIBA 10/2018
1	TransferasesIBA 10/2018
1	Glucagon-Like Peptides (Enteroglucagon)IBA 05/2018
1	Aromatic-L-Amino-Acid DecarboxylasesIBA 01/2018
1	Antisense OligonucleotidesIBA 01/2018
1	GlucosidasesIBA 01/2017
1	HydrolasesIBA 05/2014
1	dihydroethidiumIBA 05/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2014
1	Proteins (Proteins, Gene)FDA Link 05/2014
1	EnzymesIBA 05/2014
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2014
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 02/2013
1	alpha-SynucleinIBA 01/2013
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 06/2006
1	AntibodiesIBA 06/2006

Therapy/Procedure

27	Deep Brain Stimulation 01/2022 - 08/2010
4	Therapeutics 01/2022 - 12/2013
2	Electrocoagulation (Electrocautery) 01/2022 - 01/2022
1	Cell Transplantation 12/2013
1	Operative Surgical Procedures 03/2011
1	Transplantation 04/2004